Clincosm LogoSign in Get a demo

oligometastatic disease

Showing 1 - 25 of 30
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pancreatic Ductal Adenocarcinoma, Oligometastatic Disease Trial in Baltimore (FOLFIRINOX chemo)

Not yet recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Oligometastatic Disease
  • FOLFIRINOX chemotherapy
  • Baltimore, Maryland
    Johns Hopkins Hospital
Nov 2, 2023

Adenocarcinoma, Stomach Tumor, Gastroesophageal-junction Cancer Trial in Shanghai (radiation, biological, drug, procedure)

Recruiting
  • Adenocarcinoma
  • +8 more
  • Radiotherapy targeted to the primary lesion
  • +7 more
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Nov 7, 2023

Esophageal Squamous Cell Carcinoma, Oligometastatic Disease Trial in Beijing (Esophagectomy)

Active, not recruiting
  • Esophageal Squamous Cell Carcinoma
  • Oligometastatic Disease
  • Esophagectomy
  • Beijing, China
  • +1 more
Jul 11, 2023

Unresectable Hepatocellular Carcinoma, Oligometastatic Disease Trial in Beijing (SBRT plus tislelizumab and regorafenib)

Recruiting
  • Unresectable Hepatocellular Carcinoma
  • Oligometastatic Disease
  • SBRT plus tislelizumab and regorafenib
  • Beijing, Beijing, China
    Peking University Cancer Hospital
Jun 15, 2023

OligoMetastatic Patients From Rare Tumors

Not yet recruiting
  • Oligometastatic Disease
  • SBRT
  • Rozzano, Milan, Italy
    Humanitas Research Hospital
Jun 5, 2023

Colorectal Cancer, Oligometastatic Disease Trial in Australia (Local Ablative Therapy, Standard first-line systemic treatment)

Recruiting
  • Colorectal Cancer
  • Oligometastatic Disease
  • Local Ablative Therapy
  • Standard first-line systemic treatment
  • Albury, New South Wales, Australia
  • +8 more
May 15, 2023

Oligometastatic Disease Trial (IMSA101, Immune checkpoint inhibitor, PULSAR)

Not yet recruiting
  • Oligometastatic Disease
  • (no location specified)
May 5, 2023

Prediction of True Oligo-metastatic Disease.

Recruiting
  • Oligometastatic Disease
  • Genetic and immunologic assessments
  • Naples, Italy
    Alessandro Ottaiano
Apr 7, 2023

Oligometastatic Disease, Oligoprogression, Toxicity Due to Radiotherapy Trial in Canada (Single fraction SABR, Multiple fraction

Not yet recruiting
  • Oligometastatic Disease
  • +3 more
  • Single fraction SABR
  • +3 more
  • Kelowna, British Columbia, Canada
  • +4 more
Mar 23, 2023

Oligometastatic Disease Trial in Milan (radiosurgery and stereotactic ablative radiotherapy with simultaneous integrated boost,

Recruiting
  • Oligometastatic Disease
  • radiosurgery and stereotactic ablative radiotherapy with simultaneous integrated boost, respectively
  • Milan, MI, Italy
    San Raffaele Scientific Institute
Dec 23, 2022

Esophageal Squamous Cell Carcinoma, Oligometastatic Disease Trial in Guangzhou (PD-1 combined with SBRT)

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • Oligometastatic Disease
  • PD-1 combined with SBRT
  • Guangzhou, Guangdong, China
    Mian Xi
Dec 18, 2022

Liquid Biopsy in Advanced Oligometastatic NSCLC Receiving

Recruiting
  • Non-small Cell Lung Cancer
  • Oligometastatic Disease
  • ctDNA testing and whole exome sequencing
  • Guangzhou, Guangdong, China
    Guangdong Lung Cancer Institute, Guangdong Provincial People's H
Dec 5, 2022

Breast Cancer Stage IV, Oligometastatic Disease Trial (SABR)

Recruiting
  • Breast Cancer Stage IV
  • Oligometastatic Disease
  • SABR
  • Gothenburg, Västra Götalandsregionen, Sweden
    Sahlgrenska University Hospital
Oct 18, 2022

Prostate Cancer, Oligometastatic Disease Trial in United States (Prostate radiation (XRT), Systemic Therapy, Stereotactic

Recruiting
  • Prostate Cancer
  • Oligometastatic Disease
  • Prostate radiation (XRT)
  • +2 more
  • Baltimore, Maryland
  • +4 more
Oct 10, 2022

Ovarian Cancer, Oligometastatic Disease, Recurrent Ovary Cancer Trial (Stereotactic body radiotherapy)

Recruiting
  • Ovarian Neoplasms
  • +2 more
  • Stereotactic body radiotherapy
  • Campobasso, CB, Italy
  • +7 more
Sep 23, 2022

Prostate Cancer, Prostate Cancer Recurrent, Prostate Cancer Metastatic Trial in Leuven (Radiotherapy (SBRT) and/or surgery

Recruiting
  • Prostate Cancer
  • +6 more
  • Radiotherapy (SBRT) and/or surgery (metastasectomy)
  • +2 more
  • Leuven, Belgium
    University Hospitals Leuven
Jun 7, 2022

Metastatic Colorectal Cancer, Oligometastatic Disease Trial in Amersfoort, Utrecht (Stereotactic body radiation therapy (SBRT),

Not yet recruiting
  • Metastatic Colorectal Cancer
  • Oligometastatic Disease
  • Stereotactic body radiation therapy (SBRT)
  • Maintenance therapy (CAP-B or 5-FU/LV plus bevacizumab.)
  • Amersfoort, Utrecht, Netherlands
  • +3 more
May 16, 2022

Oligometastatic Disease, NSCLC, Driver Mutation Trial in Mumbai (Local Consolidative Radiation Therapy, TKI)

Recruiting
  • Oligometastatic Disease
  • +2 more
  • Local Consolidative Radiation Therapy
  • TKI
  • Mumbai, Maharashtra, India
    Tata Memorial Hospital
Mar 11, 2022

Oligometastatic Disease, Metastatic Non Small Cell Lung Cancer Trial in Mumbai (Local consolidative radiation therapy, Standard

Recruiting
  • Oligometastatic Disease
  • Metastatic Non Small Cell Lung Cancer
  • Local consolidative radiation therapy
  • Standard maintenance therapy as decided by the treating medical oncologist
  • Mumbai, Maharashtra, India
    Tata Memorial Hospital, Parel
Mar 11, 2022

Oligometastatic Disease Trial in Fuzhou, Ganzhou, Nanchang (consolidative radiotherapy)

Recruiting
  • Oligometastatic Disease
  • consolidative radiotherapy
  • Fuzhou, Fujian, China
  • +2 more
Feb 23, 2022

Pancreatic Cancer, Metastasis, Surgery Trial in Germany (nal-irinotecan (nal-iri) (Onyvide), oxaliplatin (ox), 5-fluouracil

Recruiting
  • Pancreatic Cancer
  • +3 more
  • nal-irinotecan (nal-iri) (Onyvide), oxaliplatin (ox), 5-fluouracil (5-FU), folinic acid (FA)
  • Aachen, Germany
  • +9 more
Feb 17, 2022

Patients With Anal Cancer Treated With Induction Chemotherapy

Recruiting
  • Anal Cancer
  • +4 more
    • Aarhus, Aarhus N, Denmark
    • +2 more
    Feb 9, 2022

    Oligometastatic Disease, Bone Metastases, Stereotactic Body Radiotherapy Trial in Denmark, Norway (SABR)

    Active, not recruiting
    • Oligometastatic Disease
    • +2 more
    • SABR
    • Aalborg, Denmark
    • +5 more
    Jan 27, 2022

    Prostate Cancer, Radiotherapy Side Effect, Magnetic Resonance-linac Trial in Beijing (MR-linac)

    Recruiting
    • Prostate Cancer
    • +6 more
    • MR-linac
    • Beijing, Beijing, China
      Radiotherapy Department of Cancer Hospital, Chinese Academy of M
    Dec 20, 2021

    Oligometastatic Disease, Liver Metastases, Colorectal Cancer Trial in Aurora (Gadoxetate disodium, Gadobenate dimeglumine)

    Recruiting
    • Oligometastatic Disease
    • +2 more
    • Gadoxetate disodium
    • Gadobenate dimeglumine
    • Aurora, Colorado
      University of Colorado Hospital
    Sep 27, 2021